Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscential Regulatory News (ASCL)

Share Price Information for Ascential (ASCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 314.00
Bid: 313.00
Ask: 313.40
Change: 1.80 (0.58%)
Spread: 0.40 (0.128%)
Open: 310.20
High: 314.80
Low: 308.20
Prev. Close: 312.20
ASCL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Stabilisation Notice

9 Feb 2016 07:15

RNS Number : 4442O
BofA Merrill Lynch
09 February 2016
 

 

PRE-STABILISATION ANNOUNCEMENT

 

9 February 2016

Merrill Lynch International Syndicate

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

Ascential Plc

 

Stabilisation Notice

 

Merrill Lynch International (a member firm) (contact: Raj Batra; telephone: 020 7995 3700) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 

The securities:

 

Issuer:

Ascential Plc (identifier: ASCL LN; ISIN: GB00BYM8GJ06)

Description:

Ordinary Shares (nominal value of 10p) of Ascential plc

Stabilisation:

 

Stabilisation Manager(s):

Merrill Lynch International

(Contact: Raj Batra; 020 7995 3700)

Stabilisation period expected to start on:

9 February 2016 at approximately 8am London time

Stabilisation period expected to end no later than:

9 March 2016, close of business

Existence, maximum size and conditions of use of over-allotment facility:

Over-allotment option is equivalent to 15% of the offering

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAAKFDQCBKDABK
Date   Source Headline
9th May 20245:02 pmRNSHolding(s) in Company
9th May 202411:37 amRNSResult of AGM
8th May 20246:00 pmRNSAscential
8th May 20247:00 amRNSTender Offer Results and Special Dividend
2nd May 20242:41 pmRNSHolding(s) in Company
1st May 20244:07 pmRNSHolding(s) in Company
1st May 20241:21 pmRNSHolding(s) in Company
1st May 20241:15 pmRNSTotal Voting Rights
22nd Apr 20243:39 pmRNSResults of General Meeting
18th Apr 20246:14 pmRNSDirector/PDMR Shareholding
11th Apr 202410:12 amRNSHolding(s) in Company
10th Apr 20241:48 pmRNSHolding(s) in Company
10th Apr 202410:32 amRNSNotice of AGM
9th Apr 20243:37 pmRNSHolding(s) in Company
8th Apr 20245:09 pmRNSHolding(s) in Company
5th Apr 20243:18 pmRNSHolding(s) in Company
4th Apr 20241:45 pmRNSHolding(s) in Company
4th Apr 20247:00 amRNSProposed Return of Value of £850m to Shareholders
3rd Apr 202410:39 amRNSHolding(s) in Company
2nd Apr 202412:12 pmRNSHolding(s) in Company
2nd Apr 202412:00 pmRNSTotal Voting Rights
28th Mar 20242:25 pmRNSHolding(s) in Company
28th Mar 202411:33 amRNSHolding(s) in Company
27th Mar 202412:02 pmRNSHolding(s) in Company
26th Mar 202412:16 pmRNSHolding(s) in Company
25th Mar 20243:40 pmRNSHolding(s) in Company
25th Mar 20242:26 pmRNSHolding(s) in Company
22nd Mar 20242:20 pmRNSHolding(s) in Company
21st Mar 20243:38 pmRNSHolding(s) in Company
21st Mar 20247:00 amRNSUnaudited full year results 2023
13th Mar 20244:49 pmRNSHolding(s) in Company
12th Mar 20241:24 pmRNSHolding(s) in Company
1st Mar 20242:25 pmRNSTotal Voting Rights
29th Feb 202410:22 amRNSHolding(s) in Company - Correction
27th Feb 20241:12 pmRNSHolding(s) in Company
22nd Feb 20245:01 pmRNSHolding(s) in Company
20th Feb 20241:26 pmRNSHolding(s) in Company
16th Feb 20241:06 pmRNSHolding(s) in Company
15th Feb 20244:08 pmRNSHolding(s) in Company
7th Feb 20243:40 pmRNSHolding(s) in Company
6th Feb 20244:06 pmRNSTotal Voting Rights
6th Feb 20241:41 pmRNSHolding(s) in Company
5th Feb 20241:05 pmRNSHolding(s) in Company
1st Feb 20242:48 pmRNSCompany Secretary Change
1st Feb 202411:35 amRNSCompletion of the sale of WGSN
5th Jan 20242:52 pmRNSBlock listing Interim Review
5th Jan 20247:49 amRNSDirector/PDMR Shareholding
4th Jan 202412:53 pmRNSHolding(s) in Company
2nd Jan 202411:21 amRNSUpdate on Sale Processes, Governance and Financing
29th Dec 202310:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.